Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for acute ischemic stroke clinical outcomes
IRCT20231220060484N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in ischemic stroke, sponsored by Islamic Azad University. Started Dec 2023; status: completed.
02
Drugs
melatonin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20231220060484N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231220060484N1.